ANGIOTENSIN CONVERTING ENZYME INHIBITOR REDUCES THE INCIDENCE OF ATRIAL FIBRILLATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION PATIENTS: A RETROSPECTIVE COHORT STUDY FROM THE TREATMENT OF PRESERVED CARDIAC FUNCTION HEART FAILURE WITH AN ALDOSTERONE ANTAGONIST TRIAL

Retrospective Cohort ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Aldosterone Antagonist

Pharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort Study

PLoS ONE ◽

10.1371/journal.pone.0144195 ◽

2015 ◽

Vol 10 (12) ◽

pp. e0144195 ◽

Cited By ~ 7

Author(s):

Karl Emil Nelveg-Kristensen ◽

Majbritt Busk Madsen ◽

Christian Torp-Pedersen ◽

Lars Køber ◽

Martin Egfjord ◽

...

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Cohort Study ◽

Risk Stratification ◽

Angiotensin Converting Enzyme Inhibitor ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Enzyme Inhibitor ◽

Converting Enzyme

P3565Risk of atrial fibrillation in heart failure with preserved ejection fraction: results from the treatment of cardiac function with an aldosterone antagonist (TOPCAT) Study

European Heart Journal ◽

10.1093/eurheartj/ehx504.p3565 ◽

2017 ◽

Vol 38 (suppl_1) ◽

Author(s):

J. Neefs ◽

N.W.E. Van Den Berg ◽

W.R. Berger ◽

E.R. Meulendijks ◽

J.R. Groot

Keyword(s):

Heart Failure ◽

Atrial Fibrillation ◽

Ejection Fraction ◽

Cardiac Function ◽

Aldosterone Antagonist

Clinical Outcome of Septic Patients With Heart Failure With Preserved Ejection Fraction Presenting to the Emergency Department of a Tertiary Hospital: A Retrospective Cohort Study

Frontiers in Medicine ◽

10.3389/fmed.2020.517999 ◽

2020 ◽

Vol 7 ◽

Author(s):

Ralphe Bou Chebl ◽

Iskandar Berbari ◽

Rawan Safa ◽

Ali Shami ◽

Mohammad Sabra ◽

...

Keyword(s):

Heart Failure ◽

Emergency Department ◽

Cohort Study ◽

Clinical Outcome ◽

Ejection Fraction ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Tertiary Hospital ◽

Patients With Heart Failure

250 The impact of an angiotensin converting enzyme inhibitor or an angiotensin receptor blocker on Doppler-echo diastolic and systolic parameters in heart failure with normal ejection fraction

European Journal of Echocardiography ◽

10.1016/s1525-2167(05)80103-9 ◽

2005 ◽

Vol 6 ◽

pp. S27-S27

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Angiotensin Converting Enzyme Inhibitor ◽

Angiotensin Receptor Blocker ◽

Enzyme Inhibitor ◽

Normal Ejection Fraction ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

The Impact

The Impact of Discontinuation of Sacubitril-Valsartan and Shifting to Angiotensin-Converting Enzyme inhibitor or Angiotensin Receptor Blocker in Patients with Heart Failure with Reduced Ejection Fraction

The Anatolian Journal of Cardiology ◽

10.14744/anatoljcardiol.2020.39267 ◽

2020 ◽

Author(s):

Osama A Amin

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Angiotensin Receptor Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Reduced Ejection Fraction ◽

Patients With Heart Failure ◽

The Impact

Beta-blocker, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, nitrate-hydralazine, diuretics, aldosterone antagonist, ivabradine, devices and digoxin (BANDAID2): an evidence-based mnemonic for the treatment of systolic heart failure

Internal Medicine Journal ◽

10.1111/imj.12839 ◽

2016 ◽

Vol 46 (6) ◽

pp. 653-662 ◽

Cited By ~ 5

Author(s):

N. Chia ◽

J. Fulcher ◽

A. Keech

Keyword(s):

Heart Failure ◽

Beta Blocker ◽

Angiotensin Receptor Blocker ◽

Enzyme Inhibitor ◽

Systolic Heart Failure ◽

Evidence Based ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Aldosterone Antagonist

Are angiotensin-converting enzyme inhibitors or angiotensin 2 receptor antagonists effective in heart failure with preserved ejection fraction?

Medwave ◽

10.5867/medwave.2015.02.6101 ◽

2015 ◽

Vol 15 (02) ◽

pp. e6101-e6101 ◽

Cited By ~ 1

Author(s):

Carmen Rain ◽

Gabriel Rada

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Receptor Antagonists ◽

Converting Enzyme Inhibitors

Validation of a preclinical model of heart failure with reduced ejection fraction by a dual angiotensin receptor-neprilysin inhibitor and an angiotensin-converting enzyme inhibitor

Archives of Cardiovascular Diseases Supplements ◽

10.1016/j.acvdsp.2019.02.106 ◽

2019 ◽

Vol 11 (2) ◽

pp. 230

Author(s):

M. Isabelle ◽

N. Harouki ◽

C. Ragonnet ◽

S. Butin ◽

I. Laurent ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Angiotensin Receptor Neprilysin Inhibitor

Enzyme Inhibitor ◽

Preclinical Model ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Reduced Ejection Fraction ◽

Neprilysin Inhibitor ◽

“Triple Therapy” of Heart Failure With Angiotensin-Converting Enzyme Inhibitor, Beta-Blocker, and Aldosterone Antagonist May Triple Survival Time

JACC Heart Failure ◽

10.1016/j.jchf.2014.04.012 ◽

2014 ◽

Vol 2 (5) ◽

pp. 545-548 ◽

Cited By ~ 5

Author(s):

Graham D. Cole ◽

Sheetal J. Patel ◽

Nabeela Zaman ◽

Anthony J. Barron ◽

Claire E. Raphael ◽

...

Keyword(s):

Heart Failure ◽

Survival Time ◽

Triple Therapy ◽

Angiotensin Converting Enzyme Inhibitor ◽

Beta Blocker ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Aldosterone Antagonist ◽

Converting Enzyme Inhibitor

Angiotensin-converting Enzyme Inhibitors and Outcomes in Heart Failure and Preserved Ejection Fraction

The American Journal of Medicine ◽

10.1016/j.amjmed.2013.01.004 ◽

2013 ◽

Vol 126 (5) ◽

pp. 401-410 ◽

Cited By ~ 28

Author(s):

Marjan Mujib ◽

Kanan Patel ◽

Gregg C. Fonarow ◽

Dalane W. Kitzman ◽

Yan Zhang ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors